| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Revenue | $43.0M | +729.8% |
| Cost of Revenue | $40.6M | +882.5% |
| Gross Profit | $2.4M | +130.9% |
| R&D Expense | $1.2M | -0.5% |
| SG&A Expense | $2.9M | -0.7% |
| Operating Income | -$1.6M | +45.9% |
| Pre-tax Income | -$1.1M | +44.4% |
| Net Income | -$1.1M | +44.5% |
| EPS (Basic) | -$0.15 |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | +55.2% |
| Accounts Receivable | $3.6M | +762.5% |
| Inventory | $4.8M | +33.6% |
| Current Assets | $11.3M | +89.6% |
| Total Assets | $15.6M | +40.0% |
| Current Liabilities | $11.4M | +62.1% |
| Long-term Debt | $1.7M | -54.1% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.2M | +706.0% |
| Capital Expenditures | $569K | +362.6% |
| Investing Cash Flow | -$595K | -489.1% |
| Financing Cash Flow | -$622K | -38.5% |
| Free Cash Flow | $1.6M | +436.7% |
| +53.1% |
| EPS (Diluted) | -$0.15 | +53.1% |
| Total Liabilities |
| $12.8M |
| +44.1% |
| Stockholders' Equity | $2.8M | +26.3% |